China National Pharmaceutical Group Corp. (CNPGC) known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group (SEHK: 01099, via a 51–49 joint venture, Sinopharm Industrial Investment, with Fosun Pharmaceutical), China Traditional Chinese Medicine.

Pharmaceutical

Sinopharm

Liu Yong

Cai Maisong

Chen Zhanyu

Jiang Xiuchang

Li Yang

Wu Yijian

Li Xiaojuan

Li Zhiming

Wu Tak Lung

Chen Fangruo

Wen Deyong

Ma Ping

Deng Jindong

Zhuo Fumin

Li Peiyu

Chen Qiyu

Feng Rongli

Hu Jianwei

Li Dongjiu

Yu Qingming

Yu Weifeng

Wang Kan

The Corporate Governance team at Sinopharm is responsible for overseeing the company's adherence to legal regulations and ethical standards, ensuring transparency and accountability in its operations. They develop and implement governance policies, manage board activities, and facilitate effective communication between the management and stakeholders, maintaining the integrity and reputation of the organization.

Corporate Governance

The Leadership Team at Sinopharm is responsible for strategic decision-making and guiding the overall vision of the company. Comprising several Vice Presidents and Non-executive Vice Presidents, this team focuses on driving growth, overseeing operational efficiency, and ensuring alignment with state policies in the pharmaceutical sector. Their collective expertise shapes Sinopharm's initiatives in both traditional and modern medicine, positioning the company as a leader in the healthcare industry.

Leadership Team

Sinopharm

Org chart

Board & advisors

Teams

Corporate Governance

Leadership Team

Offices

Sinopharm

Org chart

Board & advisors

Teams

Corporate Governance

Leadership Team

Offices

Related companies